Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $69.8700 (-0.99%) ($69.8200 - $70.6200) on Mon. Apr. 13, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.9% (three month average) | RSI | 57 | Latest Price | $69.8700(-0.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.4% a day on average for past five trading days. | Weekly Trend | BAX advances 1.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(48%) VYM(43%) IVE(42%) SPY(42%) VT(42%) | Factors Impacting BAX price | BAX will decline at least -0.45% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-5%) GDXJ(-3%) TIP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.45% (StdDev 0.9%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $69.89(-0.03%) | 10 Day Moving Average | $69.13(1.07%) | 20 Day Moving Average | $68.76(1.61%) | To recent high | -3.3% | To recent low | 4.3% | Market Cap | $35.646b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |